301 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
Rank Status Study
21 Recruiting Treatment, Parallel Assignment, Double Blind (Subject, Outcomes Assessor), Efficacy Study
Condition: Overactive Bladder
Interventions: Device: Electroacupuncture;   Device: Sham Electroacupuncture;   Drug: Solifenacin Succinate
22 Recruiting Randomized Trial of Tibial Nerve Stimulation Versus Pelvic Floor Exercises for Treatment of Overactive Bladder
Condition: Urge Incontinence
Intervention: Other: "Tibial stimulation" and "pelvic floor exercises"
23 Recruiting IMvigor 010 Study: Anti-Programmed Death-Ligand 1 (PD-L1) Antibody MPDL3280A Treatment Versus Observation as Adjuvant Therapy in Patients With PD-L1 Positive, High Risk Muscle Invasive Bladder Cancer After Cystectomy
Condition: Bladder Cancer, Cancer
Intervention: Biological: MPDL3280A
24 Not yet recruiting Study of Tumour Focused Radiotherapy for Bladder Cancer
Condition: Bladder Cancer
Interventions: Radiation: WBRT;   Radiation: SART;   Radiation: DART
25 Not yet recruiting Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers
Conditions: LUTS;   Benign Prostatic Hyperplasia;   Overactive Bladder
Intervention: Drug: JLP-1207
26 Recruiting Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression
Condition: Bladder Cancer
Interventions: Procedure: Transurethral Resection;   Drug: Tamsulosin
27 Not yet recruiting Biologic Mesh in Preventing Hernia in Patients With Bladder Cancer Undergoing Radical Cystectomy With Ileal Conduit Diversion
Conditions: Bladder Carcinoma;   Hernia
Intervention: Other: Acellular Cadaveric Dermal Matrix
28 Recruiting Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.
Conditions: Neoplasm, Ureter;   Intravesical Chemotherapy;   Radical Nephroureterectomy;   Neoplasm, Bladder
Interventions: Drug: Immediate instillation of intravesical chemotherapy-Epirubicin-;   Drug: Maintainance therapy of intravesical chemotherapy-Epirubicin-
29 Not yet recruiting Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer
Conditions: Bladder Carcinoma;   Post-operative Pain
Interventions: Other: Placebo;   Other: Questionnaire Administration;   Drug: Ropivacaine Hydrochloride
30 Recruiting Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
Conditions: Breast Cancer;   Prostate Cancer;   Urinary Bladder Cancer
Interventions: Drug: Injection of 68Ga-NOTA-AE105;   Device: Positron Emission Tomography scans
31 Not yet recruiting Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer
Conditions: Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;   Recurrent Bladder Carcinoma;   Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;   Regional Urothelial Carcinoma of the Renal Pelvis and Ureter;   Stage III Bladder Urothelial Carcinoma;   Stage III Urethral Cancer;   Stage IV Bladder Urothelial Carcinoma;   Stage IV Urethral Cancer;   Urethral Urothelial Carcinoma
Interventions: Drug: Pembrolizumab;   Drug: Docetaxel;   Drug: Gemcitabine Hydrochloride
32 Recruiting Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms
Condition: Urinary Bladder Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
33 Not yet recruiting A Two-Dimensional Dose-Finding Study of Ixazomib in Combination With Gemcitabine and Doxorubicin, Followed by a Phase II Extension to Assess the Efficacy of This Combination in Metastatic, Surgically Unresectable Urothelial Cancer
Condition: Bladder Cancer
Interventions: Drug: Ixazomib;   Drug: Gemcitabine;   Drug: Doxorubicin
34 Not yet recruiting A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
Conditions: Cystitis, Interstitial;   Painful Bladder Syndrome
Interventions: Device: LiRIS®;   Device: LiRIS Placebo
35 Recruiting Changes of microRNA Expression in Obstructive and Neurogenic Bladder Dysfunction
Condition: Disorder of the Lower Urinary Tract
Interventions: Procedure: Bladder biopsy;   Procedure: Urodynamic study
36 Recruiting Determinants of Bladder Cancer Recurrence Study (The DETER Study)
Condition: Bladder Cancer
Interventions: Behavioral: questionnaires;   Other: Saliva and/or urine sample
37 Recruiting Cystoscopic Ablation Via RF Energy Clinical Trial
Condition: Overactive Bladder
Intervention: Device: Amphora OAB Device
38 Recruiting Adjuvant Radiotherapy After Cystectomy for Muscle Invasive Bladder Cancer
Condition: Toxicity
Intervention: Radiation: Adjuvant EBRT
39 Recruiting A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions
Conditions: Cystitis, Interstitial;   Ulcer
Interventions: Drug: LiRIS®;   Drug: LiRIS Placebo
40 Not yet recruiting Urinary Neurotrophin Levels in Healthy Children
Condition: Overactive Bladder

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years